VRAX peer analysis
VRAX (VRAX) against its competitors: price, today's move, 1-year return and market value side by side.
- VRAX's peers: ARTL (Artelo Biosciences), DRMA (Dermata Therapeutics), ELAB (PMGC), GTBP (GT Biopharma), MLEC (Moolec Science), NCEL (NewcelX), XRTX (XORTX Therapeutics).
VRAX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARTL Artelo Biosciences | $1.45 | -3.33% | -97.10% | $5.05M |
| DRMA Dermata Therapeutics | $0.51 | -4.14% | -79.10% | $2.51M |
| ELAB PMGC | $1.17 | -7.87% | -99.90% | $1.37M |
| GTBP GT Biopharma | $3.18 | -7.29% | -81.29% | $6.80M |
| MLEC Moolec Science | $0.85 | -39.29% | -90.56% | – |
| NCEL NewcelX | $2.69 | 1.51% | -18.73% | $1.21M |
| XRTX XORTX Therapeutics | $0.81 | -8.98% | -70.29% | $1.47M |
| VRAX Virax Biolabs | $0.38 | -11.40% | -96.54% | $512.44K |